Prevalence of fertility discussions between young adult colorectal cancer survivors and their providers.
Julia Stal(Dana-Farber Cancer Institute), Kimberly A. Miller(University of Southern California), Joel Milam, Heinz‐Josef Lenz(University of Southern California), Serena Y Yi(Keck Hospital of USC), Afsaneh Barzi(City Of Hope National Medical Center), Sally Cohen‐Cutler(Children's Hospital of Los Angeles), David R. Freyer(University of Southern California), Phuong Gallagher(Army and Navy Club)
Cited by 1
Related Papers
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
|The Lancet Oncology|2017|2.8k
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
|Journal of Clinical Oncology|2018|2.1k
Prognostic and Predictive Relevance of Primary Tumor Location in Patients With <i>RAS </i>Wild-Type Metastatic Colorectal Cancer
|JAMA Oncology|2016|722
Randomized Study of Two Chemotherapy Regimens for Treatment of Low-Grade Glioma in Young Children: A Report From the Children's Oncology Group
|Journal of Clinical Oncology|2012|433